View Future GrowthReGen III 過去の業績過去 基準チェック /06ReGen III は平均年間 10.1% の収益成長を遂げていますが、Oil and Gas 業界では年間 収益成長率 となっています。8.4% です。主要情報10.09%収益成長率14.52%EPS成長率Oil and Gas 業界の成長33.67%収益成長率n/a株主資本利益率n/aネット・マージンn/a前回の決算情報31 Dec 2025最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Apr 07ReGen III Corp., Annual General Meeting, May 29, 2026ReGen III Corp., Annual General Meeting, May 29, 2026. Location: british columbia, vancouver Canadaお知らせ • Apr 03ReGen III Corp. announced that it has received CAD 4.037572 million in funding from Embley Park Foundation and other investorsOn April 1, 2026, ReGen III Corp. closed the oversubscribed transaction. The company issued 3,000,000 units at an issue price of CAD 0.20 for gross proceeds of CAD 600,000 in its third and final tranche. The transaction includes participation from, Brad Kotush for 125,000 units for gross proceeds of CAD 25,000, Embley Park Foundation for 1,125,000 units for gross proceeds of CAD 225,000 and Liam Gallacher for 1,625,000 units for gross proceeds of CAD 325,000. Over the course of closing the three tranches of the offering, the company has issued 20,187,860 units for aggregate gross proceeds of CAD 4,037,572. All securities issued in the final tranche will be subject to a statutory four-month hold period ending August 2, 2026. The company paid finders' fees of CAD 5,000 in cash for final tranche. The company paid total CAD 80,750 as finder's fees related to the offering. The closing of the offering is subject to receipt of al necessary regulatory approvals, including final approval by the TSX Venture Exchange. Insiders of the company purchased 2,875,000 units, representing 14.24% of aggregate units issued in the offering, with the associated common shares representing approximately 1.86% of the issued and outstanding common shares following the closing of the final tranche. The private placement was approved by the board of directors of the company.お知らせ • Mar 05ReGen III Corp. announced that it expects to receive CAD 4 million in fundingReGen III Corp. announces a non-brokered private placement to issue 20,000,000 units of the company at a price of CAD 0.20 per unit for gross proceeds of CAD 4,000,000 on March 4, 2026. Each unit will consist of one common share in the capital of the company and one-half of one common share purchase warrant. Each warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.30 per warrant share for a period of three years from the date of issuance. The closing of the offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange. In connection with the offering, the company may pay certain finders' fees subject to compliance with applicable securities laws and the rules of the exchange. The securities issued pursuant to the offering will be subject to a statutory four-month hold period.お知らせ • May 27ReGen III Corp. announced that it expects to receive CAD 2 million in fundingReGen III Corp announced a non brokered private placement to issue 10,000,000 Units at a price of CAD 0.2 per unit for aggregate gross proceeds of CAD 2,000,000. Each Unit will consist of One common share and one-half of one common share purchase warrant. Each Warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.45 per Warrant for a period of two years from the date of issuance. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange.お知らせ • Dec 03+ 1 more updateReGen III Corp. Announces Chief Executive Officer ChangesReGen III Corp. announced the appointment of Tony Weatherill as Chief Executive Officer, effective December 2, 2024. Mr. Weatherill joins ReGen III with a distinguished career spanning over three decades in the global lubricants and petrochemicals sectors, most recently with H.F. Sinclair Corporation ("H.F. Sinclair") and Petro-Canada Lubricants ("PCL"). Tony Weatherill brings an impressive track record of driving commercial success, operational excellence, and innovation across billion-dollar organizations. From 2020 to 2023, Tony served as Senior Vice President, Commercial, at H.F. Sinclair, where he was instrumental in driving commercial and marketing activities across a $3.9 billion international enterprise operating in over 90 countries. Tony's leadership was marked by significant improvements in revenues and profitability, including more than doubling of global sales and significant enhancements in EBITDA margins. With oversight for 1,400 indirect reports, Tony orchestrated multiple successful acquisitions, executed high-impact operational improvements and spearheaded substantial volume and margin growth initiatives. Concurrently, from 2019 to 2023, Tony also served as President of Petro-Canada Lubricants (a division of H.F. Sinclair), where he was responsible for commercial strategy, global business development, and overall financial and operational performance. Tony managed and optimized a family of globally recognized finished lubricant, base oil, and specialties brands (including Red Giant Oil, Sonneborn, Sinclair and Petro-Canada Lubricants) and oversaw North America's largest Group III base oil production facility in Mississauga, Ontario. In addition to his many successful commercial roles, Tony developed extensive product expertise, technical acumen, and market insights as Vice President of Global Research and Development at PCL and in his previous roles at ExxonMobil and Chemtura. Effective December 2, 2024, Mark Redcliffe, current CEO of ReGen III, will transition to the newly created roles of Executive Vice-President and Chief Strategy Officer, continuing his invaluable work in the areas of offtake, feedstock, intellectual property, capital markets, and strategic opportunities, among others.お知らせ • Nov 25ReGen III Corp. announced that it has received CAD 0.89 million in fundingOn November 25, 2024, ReGen III Corp. closed the transaction. The company issued 1,800,000 Units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 360,000 in its final tranche. On an aggregate basis, across the initial and Final Tranche of the non-brokered private placement, the Company issued 4,450,000 Units for gross proceeds of CAD 890,000. All securities issued in the Final Tranche are subject to a hold period expiring on March 23, 2025. In connection with the Final Tranche, the Company paid aggregate finders' fees of CAD 7,000 in cash. The Offering is subject to the final approval of the Exchange.お知らせ • Oct 22ReGen III Corp., Annual General Meeting, Dec 19, 2024ReGen III Corp., Annual General Meeting, Dec 19, 2024. Location: british columbia, vancouver Canadaお知らせ • Oct 08ReGen III Corp. announced that it expects to receive CAD 0.5 million in fundingReGen III Corp. announced a non-brokered private placement of up to 2,500,000 units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 500,000 on October 7, 2024. Each unit will consist of one common share and one common share purchase warrant entitling the holder to purchase a further common share at a price of CAD 0.30 for a period of 36 months after the closing. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the Exchange.お知らせ • Sep 24ReGen III Corp. Announces CEO ChangesReGen III Corp. announced that effective immediately Greg Clarkes, CEO and Chairman of the Board, has stepped down from his role as CEO for personal reasons. Mr. Clarkes will continue to serve as Chairman of the Board, providing ongoing leadership and guidance to the Company. Mr. Clarkes founded ReGen III in 2017, securing the underlying process patent suite and re-capitalizing the firm's strategic shift to high-value re-refining. Amongst other corporate milestones, Mr. Clarkes was integral to securing FEL2 financing and negotiating the Company's multi-year offtake agreement with bp Products North America. Mr. Clarkes was also a strong supporter of building out the Company's intellectual property, wherein the Company has validated, de-risked and protected its proprietary ReGen process through numerous technical studies and 32 pending or awarded patents. Effective immediately, Mark Redcliffe, President of ReGen III, will assume the roles of CEO and President.お知らせ • Jul 16ReGen III Corp. announced that it has received CAD 1.075 million in fundingOn July 15, 2024, ReGen III Corp. closed the transaction. The company has issued 300 Convertible Debenture Units at a price of CAD 1,000 per unit for aggregate gross proceeds of CAD 300,000 in its second and final tranche closing. The company has now issued total 1,075 Convertible Debenture Units at a price of CAD 1,000 per unit for total gross proceeds of CAD 1,075,000 in the transaction. The Debentures and Warrants issued in this final tranche and any underlying common shares are subject to a hold period expiring on November 16, 2024. A director of the company acquired ownership or control over an additional 100 units in the final tranche, the underlying debenture and warrants which if immediately converted and exercised respectively as of closing would result in the issue of 281,818 common shares representing approximately 0.238% of the then issued and outstanding common shares.お知らせ • Apr 30ReGen III Corp. announced that it expects to receive CAD 2 million in fundingReGen III Corp. announced a non-brokered private placement of up to 2,000 convertible debenture units at a price of CAD 1,000 per unit for gross proceeds of up to CAD 2,000,000 on April 30, 2024. Each unit will consist of a CAD 1,000 in principal amount of unsecured convertible debenture and 1,000 common share purchase warrants of the company. Each warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing. The debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the company may elect to pay outstanding interest in common shares at a price per share equal to the volume-weighted average price of the common shares on the TSX Venture Exchange for the five trading days prior to the date such interest is due. The debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share. After four months, the company may redeem the debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or interest shares or a combination thereof. Finder fees may be paid in accordance with the policies of the exchange, subject to compliance with applicable law and exchange approval. The placement may be closed in one or more tranches. The debentures, the warrants and any underlying common shares will be subject to a four-month hold period from closing. The certificates representing the debentures and the warrants will contain such additional terms and conditions as are considered necessary or advisable by the company. The placement, including but not limited to the payment of any finder fees and any future issuance of interest shares, remains subject to exchange approval.お知らせ • Oct 31ReGen III Corp. announced that it expects to receive CAD 5 million in fundingReGen III Corp announces private placement of 5,000 Convertible Debenture Units at a price of CAD 1,000 per Unit for gross proceeds of CAD 5,000,000 on October 30, 2023.Each Unit will consist of a $1,000 in principal amount of unsecured convertible debenture (a "Debenture") and 1,000 common share purchase warrants of the Company (a "Warrant"). Each Warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing.The Debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the Company may elect to pay outstanding interest in common shares ("Interest Shares") at a price per share equal to the volume weighted average price of the common shares on the TSX Venture Exchange (the "Exchange") for the 5 trading days prior to the date such interest is due. The Debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share.After 4 months, the Company may redeem the Debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or Interest Shares or a combination thereof. The Placement may be closed in one or more tranches. The Debentures, the Warrants and any underlying common shares will be subject to a four month hold period from closing.お知らせ • Oct 21ReGen III Corp., Annual General Meeting, Dec 21, 2023ReGen III Corp., Annual General Meeting, Dec 21, 2023. Location: Vancouver, BC Vancouver Canadaお知らせ • Jun 23ReGen III Corp. Appoints Rick Low as Chief Financial OfficerReGen III Corp. announced the appointment of Rick Low as Chief Financial Officer, effective immediately. Mr. Low, most recently the company's Manager, Finance & Accounting, will now assume the responsibilities previously held by Steve Martin. With over 25 years of progressive management experience in various industries, both in Canada and overseas, Mr. Low brings a wealth of expertise to his new role. He possesses a remarkable track record of more than 15 years in senior management, including extensive experience as the Company's original Chief Financial Officer from September 2012 to October 2021. Mr. Low has successfully overseen the finance and accounting functions of a pre-revenue company, leading it through the critical stages of feasibility, construction, development and ultimately, commercial production and revenue generation. Throughout his career, Mr. Low has been instrumental in raising significant debt and equity financings, as well as facilitating applications for listing on stock exchanges. His comprehensive understanding of financial operations, combined with his strategic vision, will greatly contribute to helping ReGen III achieve its corporate milestones and growth plans.収支内訳ReGen III の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:ISRJ.F 収益、費用、利益 ( )CAD Millions日付収益収益G+A経費研究開発費31 Dec 250-43030 Sep 250-33030 Jun 250-33031 Mar 250-33031 Dec 240-43130 Sep 240-54130 Jun 240-54131 Mar 240-65131 Dec 230-65030 Sep 230-65030 Jun 230-65031 Mar 230-75131 Dec 220-126630 Sep 220-156930 Jun 220-166931 Mar 220-96831 Dec 210-56430 Sep 210-15130 Jun 210-14031 Mar 210-74031 Dec 200-52030 Sep 200-52030 Jun 200-53031 Mar 200-63031 Dec 190-64030 Sep 190-64030 Jun 190-65031 Mar 190-77031 Dec 180-88030 Sep 180-88030 Jun 180-87031 Mar 180-76031 Dec 170-55030 Sep 170-54030 Jun 170-43031 Mar 170-22031 Dec 160-22030 Sep 160-32030 Jun 160-32031 Mar 160-42031 Dec 150-32030 Sep 150-220質の高い収益: ISRJ.Fは現在利益が出ていません。利益率の向上: ISRJ.Fは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: ISRJ.Fは利益を出していないが、過去 5 年間で年間10.1%の割合で損失を削減してきた。成長の加速: ISRJ.Fの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: ISRJ.Fは利益が出ていないため、過去 1 年間の収益成長をOil and Gas業界 ( 3.9% ) と比較することは困難です。株主資本利益率高いROE: ISRJ.Fの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YEnergy 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 12:51終値2026/03/27 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋ReGen III Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Kimberly Thompson-HedlinCanaccord GenuityAdam GillParadigm Capital, Inc.
お知らせ • Apr 07ReGen III Corp., Annual General Meeting, May 29, 2026ReGen III Corp., Annual General Meeting, May 29, 2026. Location: british columbia, vancouver Canada
お知らせ • Apr 03ReGen III Corp. announced that it has received CAD 4.037572 million in funding from Embley Park Foundation and other investorsOn April 1, 2026, ReGen III Corp. closed the oversubscribed transaction. The company issued 3,000,000 units at an issue price of CAD 0.20 for gross proceeds of CAD 600,000 in its third and final tranche. The transaction includes participation from, Brad Kotush for 125,000 units for gross proceeds of CAD 25,000, Embley Park Foundation for 1,125,000 units for gross proceeds of CAD 225,000 and Liam Gallacher for 1,625,000 units for gross proceeds of CAD 325,000. Over the course of closing the three tranches of the offering, the company has issued 20,187,860 units for aggregate gross proceeds of CAD 4,037,572. All securities issued in the final tranche will be subject to a statutory four-month hold period ending August 2, 2026. The company paid finders' fees of CAD 5,000 in cash for final tranche. The company paid total CAD 80,750 as finder's fees related to the offering. The closing of the offering is subject to receipt of al necessary regulatory approvals, including final approval by the TSX Venture Exchange. Insiders of the company purchased 2,875,000 units, representing 14.24% of aggregate units issued in the offering, with the associated common shares representing approximately 1.86% of the issued and outstanding common shares following the closing of the final tranche. The private placement was approved by the board of directors of the company.
お知らせ • Mar 05ReGen III Corp. announced that it expects to receive CAD 4 million in fundingReGen III Corp. announces a non-brokered private placement to issue 20,000,000 units of the company at a price of CAD 0.20 per unit for gross proceeds of CAD 4,000,000 on March 4, 2026. Each unit will consist of one common share in the capital of the company and one-half of one common share purchase warrant. Each warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.30 per warrant share for a period of three years from the date of issuance. The closing of the offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange. In connection with the offering, the company may pay certain finders' fees subject to compliance with applicable securities laws and the rules of the exchange. The securities issued pursuant to the offering will be subject to a statutory four-month hold period.
お知らせ • May 27ReGen III Corp. announced that it expects to receive CAD 2 million in fundingReGen III Corp announced a non brokered private placement to issue 10,000,000 Units at a price of CAD 0.2 per unit for aggregate gross proceeds of CAD 2,000,000. Each Unit will consist of One common share and one-half of one common share purchase warrant. Each Warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.45 per Warrant for a period of two years from the date of issuance. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange.
お知らせ • Dec 03+ 1 more updateReGen III Corp. Announces Chief Executive Officer ChangesReGen III Corp. announced the appointment of Tony Weatherill as Chief Executive Officer, effective December 2, 2024. Mr. Weatherill joins ReGen III with a distinguished career spanning over three decades in the global lubricants and petrochemicals sectors, most recently with H.F. Sinclair Corporation ("H.F. Sinclair") and Petro-Canada Lubricants ("PCL"). Tony Weatherill brings an impressive track record of driving commercial success, operational excellence, and innovation across billion-dollar organizations. From 2020 to 2023, Tony served as Senior Vice President, Commercial, at H.F. Sinclair, where he was instrumental in driving commercial and marketing activities across a $3.9 billion international enterprise operating in over 90 countries. Tony's leadership was marked by significant improvements in revenues and profitability, including more than doubling of global sales and significant enhancements in EBITDA margins. With oversight for 1,400 indirect reports, Tony orchestrated multiple successful acquisitions, executed high-impact operational improvements and spearheaded substantial volume and margin growth initiatives. Concurrently, from 2019 to 2023, Tony also served as President of Petro-Canada Lubricants (a division of H.F. Sinclair), where he was responsible for commercial strategy, global business development, and overall financial and operational performance. Tony managed and optimized a family of globally recognized finished lubricant, base oil, and specialties brands (including Red Giant Oil, Sonneborn, Sinclair and Petro-Canada Lubricants) and oversaw North America's largest Group III base oil production facility in Mississauga, Ontario. In addition to his many successful commercial roles, Tony developed extensive product expertise, technical acumen, and market insights as Vice President of Global Research and Development at PCL and in his previous roles at ExxonMobil and Chemtura. Effective December 2, 2024, Mark Redcliffe, current CEO of ReGen III, will transition to the newly created roles of Executive Vice-President and Chief Strategy Officer, continuing his invaluable work in the areas of offtake, feedstock, intellectual property, capital markets, and strategic opportunities, among others.
お知らせ • Nov 25ReGen III Corp. announced that it has received CAD 0.89 million in fundingOn November 25, 2024, ReGen III Corp. closed the transaction. The company issued 1,800,000 Units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 360,000 in its final tranche. On an aggregate basis, across the initial and Final Tranche of the non-brokered private placement, the Company issued 4,450,000 Units for gross proceeds of CAD 890,000. All securities issued in the Final Tranche are subject to a hold period expiring on March 23, 2025. In connection with the Final Tranche, the Company paid aggregate finders' fees of CAD 7,000 in cash. The Offering is subject to the final approval of the Exchange.
お知らせ • Oct 22ReGen III Corp., Annual General Meeting, Dec 19, 2024ReGen III Corp., Annual General Meeting, Dec 19, 2024. Location: british columbia, vancouver Canada
お知らせ • Oct 08ReGen III Corp. announced that it expects to receive CAD 0.5 million in fundingReGen III Corp. announced a non-brokered private placement of up to 2,500,000 units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 500,000 on October 7, 2024. Each unit will consist of one common share and one common share purchase warrant entitling the holder to purchase a further common share at a price of CAD 0.30 for a period of 36 months after the closing. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the Exchange.
お知らせ • Sep 24ReGen III Corp. Announces CEO ChangesReGen III Corp. announced that effective immediately Greg Clarkes, CEO and Chairman of the Board, has stepped down from his role as CEO for personal reasons. Mr. Clarkes will continue to serve as Chairman of the Board, providing ongoing leadership and guidance to the Company. Mr. Clarkes founded ReGen III in 2017, securing the underlying process patent suite and re-capitalizing the firm's strategic shift to high-value re-refining. Amongst other corporate milestones, Mr. Clarkes was integral to securing FEL2 financing and negotiating the Company's multi-year offtake agreement with bp Products North America. Mr. Clarkes was also a strong supporter of building out the Company's intellectual property, wherein the Company has validated, de-risked and protected its proprietary ReGen process through numerous technical studies and 32 pending or awarded patents. Effective immediately, Mark Redcliffe, President of ReGen III, will assume the roles of CEO and President.
お知らせ • Jul 16ReGen III Corp. announced that it has received CAD 1.075 million in fundingOn July 15, 2024, ReGen III Corp. closed the transaction. The company has issued 300 Convertible Debenture Units at a price of CAD 1,000 per unit for aggregate gross proceeds of CAD 300,000 in its second and final tranche closing. The company has now issued total 1,075 Convertible Debenture Units at a price of CAD 1,000 per unit for total gross proceeds of CAD 1,075,000 in the transaction. The Debentures and Warrants issued in this final tranche and any underlying common shares are subject to a hold period expiring on November 16, 2024. A director of the company acquired ownership or control over an additional 100 units in the final tranche, the underlying debenture and warrants which if immediately converted and exercised respectively as of closing would result in the issue of 281,818 common shares representing approximately 0.238% of the then issued and outstanding common shares.
お知らせ • Apr 30ReGen III Corp. announced that it expects to receive CAD 2 million in fundingReGen III Corp. announced a non-brokered private placement of up to 2,000 convertible debenture units at a price of CAD 1,000 per unit for gross proceeds of up to CAD 2,000,000 on April 30, 2024. Each unit will consist of a CAD 1,000 in principal amount of unsecured convertible debenture and 1,000 common share purchase warrants of the company. Each warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing. The debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the company may elect to pay outstanding interest in common shares at a price per share equal to the volume-weighted average price of the common shares on the TSX Venture Exchange for the five trading days prior to the date such interest is due. The debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share. After four months, the company may redeem the debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or interest shares or a combination thereof. Finder fees may be paid in accordance with the policies of the exchange, subject to compliance with applicable law and exchange approval. The placement may be closed in one or more tranches. The debentures, the warrants and any underlying common shares will be subject to a four-month hold period from closing. The certificates representing the debentures and the warrants will contain such additional terms and conditions as are considered necessary or advisable by the company. The placement, including but not limited to the payment of any finder fees and any future issuance of interest shares, remains subject to exchange approval.
お知らせ • Oct 31ReGen III Corp. announced that it expects to receive CAD 5 million in fundingReGen III Corp announces private placement of 5,000 Convertible Debenture Units at a price of CAD 1,000 per Unit for gross proceeds of CAD 5,000,000 on October 30, 2023.Each Unit will consist of a $1,000 in principal amount of unsecured convertible debenture (a "Debenture") and 1,000 common share purchase warrants of the Company (a "Warrant"). Each Warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing.The Debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the Company may elect to pay outstanding interest in common shares ("Interest Shares") at a price per share equal to the volume weighted average price of the common shares on the TSX Venture Exchange (the "Exchange") for the 5 trading days prior to the date such interest is due. The Debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share.After 4 months, the Company may redeem the Debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or Interest Shares or a combination thereof. The Placement may be closed in one or more tranches. The Debentures, the Warrants and any underlying common shares will be subject to a four month hold period from closing.
お知らせ • Oct 21ReGen III Corp., Annual General Meeting, Dec 21, 2023ReGen III Corp., Annual General Meeting, Dec 21, 2023. Location: Vancouver, BC Vancouver Canada
お知らせ • Jun 23ReGen III Corp. Appoints Rick Low as Chief Financial OfficerReGen III Corp. announced the appointment of Rick Low as Chief Financial Officer, effective immediately. Mr. Low, most recently the company's Manager, Finance & Accounting, will now assume the responsibilities previously held by Steve Martin. With over 25 years of progressive management experience in various industries, both in Canada and overseas, Mr. Low brings a wealth of expertise to his new role. He possesses a remarkable track record of more than 15 years in senior management, including extensive experience as the Company's original Chief Financial Officer from September 2012 to October 2021. Mr. Low has successfully overseen the finance and accounting functions of a pre-revenue company, leading it through the critical stages of feasibility, construction, development and ultimately, commercial production and revenue generation. Throughout his career, Mr. Low has been instrumental in raising significant debt and equity financings, as well as facilitating applications for listing on stock exchanges. His comprehensive understanding of financial operations, combined with his strategic vision, will greatly contribute to helping ReGen III achieve its corporate milestones and growth plans.